Connor, Clark & Lunn Investment Management (CC&L)’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.2M | Buy |
59,807
+38,217
| +177% | +$11M | 0.06% | 273 |
|
|
2025
Q1 | $6.66M | Buy |
21,590
+7,058
| +49% | +$2.18M | 0.03% | 423 |
|
|
2024
Q4 | $5.13M | Buy |
14,532
+3,573
| +33% | +$1.26M | 0.02% | 478 |
|
|
2024
Q3 | $3.93M | Sell |
10,959
-42,538
| -80% | -$15.2M | 0.02% | 497 |
|
|
2024
Q2 | $17M | Buy |
53,497
+48,105
| +892% | +$15.3M | 0.07% | 205 |
|
|
2024
Q1 | $1.24M | Buy |
+5,392
| New | +$1.24M | 0.01% | 820 |
|
|
2023
Q1 | – | Sell |
-2,853
| Closed | -$793K | – | 1466 |
|
|
2022
Q4 | $793K | Sell |
2,853
-53,934
| -95% | -$15M | ﹤0.01% | 762 |
|
|
2022
Q3 | $11.9M | Sell |
56,787
-4,621
| -8% | -$968K | 0.08% | 182 |
|
|
2022
Q2 | $14.5M | Buy |
61,408
+8,606
| +16% | +$2.03M | 0.09% | 168 |
|
|
2022
Q1 | $9.47M | Buy |
52,802
+13,507
| +34% | +$2.42M | 0.05% | 234 |
|
|
2021
Q4 | $8.49M | Buy |
39,295
+24,105
| +159% | +$5.21M | 0.04% | 257 |
|
|
2021
Q3 | $2.8M | Buy |
+15,190
| New | +$2.8M | 0.01% | 459 |
|
|
2021
Q1 | – | Sell |
-4,258
| Closed | -$646K | – | 1100 |
|
|
2020
Q4 | $646K | Buy |
+4,258
| New | +$646K | ﹤0.01% | 693 |
|
|
2019
Q4 | – | Sell |
-44,858
| Closed | -$3.58M | – | 1103 |
|
|
2019
Q3 | $3.58M | Sell |
44,858
-24,217
| -35% | -$1.93M | 0.02% | 314 |
|
|
2019
Q2 | $5.39M | Buy |
69,075
+49,975
| +262% | +$3.9M | 0.03% | 274 |
|
|
2019
Q1 | $2.24M | Sell |
19,100
-26,075
| -58% | -$3.06M | 0.01% | 395 |
|
|
2018
Q4 | $4.92M | Sell |
45,175
-10,025
| -18% | -$1.09M | 0.03% | 273 |
|
|
2018
Q3 | $7.06M | Sell |
55,200
-15,974
| -22% | -$2.04M | 0.04% | 263 |
|
|
2018
Q2 | $8.05M | Buy |
71,174
+925
| +1% | +$105K | 0.05% | 241 |
|
|
2018
Q1 | $7.89M | Sell |
70,249
-10,364
| -13% | -$1.16M | 0.05% | 229 |
|
|
2017
Q4 | $11.9M | Sell |
80,613
-12,483
| -13% | -$1.85M | 0.07% | 184 |
|
|
2017
Q3 | $10.9M | Buy |
93,096
+22,596
| +32% | +$2.65M | 0.07% | 198 |
|
|
2017
Q2 | $9.15M | Buy |
+70,500
| New | +$9.15M | 0.06% | 194 |
|
|
2016
Q3 | – | Sell |
-42,400
| Closed | -$4.49M | – | 922 |
|
|
2016
Q2 | $4.49M | Buy |
42,400
+5,500
| +15% | +$583K | 0.03% | 252 |
|
|
2016
Q1 | $4.11M | Sell |
36,900
-900
| -2% | -$100K | 0.03% | 245 |
|
|
2015
Q4 | $5.92M | Buy |
37,800
+27,200
| +257% | +$4.26M | 0.05% | 193 |
|
|
2015
Q3 | $1.39M | Buy |
+10,600
| New | +$1.39M | 0.01% | 350 |
|
|
2015
Q1 | – | Sell |
-14,700
| Closed | -$1.9M | – | 623 |
|
|
2014
Q4 | $1.9M | Buy |
14,700
+5,700
| +63% | +$738K | 0.02% | 234 |
|
|
2014
Q3 | $1.16M | Buy |
9,000
+5,700
| +173% | +$733K | 0.01% | 281 |
|
|
2014
Q2 | $311K | Sell |
3,300
-32,100
| -91% | -$3.03M | ﹤0.01% | 451 |
|
|
2014
Q1 | $3.67M | Buy |
35,400
+6,600
| +23% | +$685K | 0.03% | 193 |
|
|
2013
Q4 | $3.46M | Buy |
28,800
+10,200
| +55% | +$1.23M | 0.03% | 196 |
|
|
2013
Q3 | $1.51M | Buy |
18,600
+500
| +3% | +$40.5K | 0.01% | 227 |
|
|
2013
Q2 | $1.26M | Buy |
+18,100
| New | +$1.26M | 0.01% | 240 |
|